A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Some of the children at the Royal Free Hospital in London were less than impressed with their visit from Alex Oxlade-Chamberlain.
How closely have you been paying attention to the news this week? Test your memory with our Friday quiz.
The FBI said three key elements of the Sony Pictures cyber attack led them to identify the administration in Pyongyang as the culprits.